Risk factors for COVID-19 infection in people with 4th dose of bivalent mRNA vaccines in general medicine from October 2022 to February 2023

Turabian Jose Luis
{"title":"Risk factors for COVID-19 infection in people with 4th dose of bivalent mRNA vaccines in general medicine from October 2022 to February 2023","authors":"Turabian Jose Luis","doi":"10.17352/2455-5479.000198","DOIUrl":null,"url":null,"abstract":"Background: Risk factors of COVID-19 infection in people vaccinated with the 4th dose of mRNA COVID-19 vaccine remain the subject of debate. Objective: To identify risk and protective factors of COVID-19 in vaccinated people with 4th dose of bivalent mRNA vaccines. Location: General Practitioner consultation in Toledo (Spain). Methodology: Longitudinal and prospective study of cases and controls of adult patients with or without COVID-19 infection in vaccinated people with 4th dose of bivalent mRNA vaccines, from October 1, 2022, to February 28, 2023. Results: Five cases of COVID-19 infections in vaccinated people with 4th dose were included, which were compared with 52 controls (with 4th dose and without COVID-19 after the booster). The risk factors for COVID-19 infection with the 4th dose were: Women (RR = 1.67), Socio-Health Care Workers (RR = 10.39; p = 0.0349), Chronic Diseases of the blood (RR = 6.9. p = 0.0322), Chronic Diseases of Endocrine (RR = 2.72. p = 0.039425), and Chronic Diseases of Circulatory system (RR = 1.87). Conclusion: In the general practice setting in Toledo, Spain, being a socio-health care worker and having chronic diseases presumably associated with immunosuppression were statistically significant risk factors for COVID-19 infection in people vaccinated with the 4th dose of bivalent mRNA vaccines. The most exposed or immunosuppressed people continue to be at risk of becoming infected with SARS-CoV-2 despite having received the 4th dose of the mRNA COVID-19 vaccine, so other preventive methods in these groups are advisable.","PeriodicalId":87221,"journal":{"name":"Archives of community medicine and public health","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of community medicine and public health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17352/2455-5479.000198","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Background: Risk factors of COVID-19 infection in people vaccinated with the 4th dose of mRNA COVID-19 vaccine remain the subject of debate. Objective: To identify risk and protective factors of COVID-19 in vaccinated people with 4th dose of bivalent mRNA vaccines. Location: General Practitioner consultation in Toledo (Spain). Methodology: Longitudinal and prospective study of cases and controls of adult patients with or without COVID-19 infection in vaccinated people with 4th dose of bivalent mRNA vaccines, from October 1, 2022, to February 28, 2023. Results: Five cases of COVID-19 infections in vaccinated people with 4th dose were included, which were compared with 52 controls (with 4th dose and without COVID-19 after the booster). The risk factors for COVID-19 infection with the 4th dose were: Women (RR = 1.67), Socio-Health Care Workers (RR = 10.39; p = 0.0349), Chronic Diseases of the blood (RR = 6.9. p = 0.0322), Chronic Diseases of Endocrine (RR = 2.72. p = 0.039425), and Chronic Diseases of Circulatory system (RR = 1.87). Conclusion: In the general practice setting in Toledo, Spain, being a socio-health care worker and having chronic diseases presumably associated with immunosuppression were statistically significant risk factors for COVID-19 infection in people vaccinated with the 4th dose of bivalent mRNA vaccines. The most exposed or immunosuppressed people continue to be at risk of becoming infected with SARS-CoV-2 despite having received the 4th dose of the mRNA COVID-19 vaccine, so other preventive methods in these groups are advisable.
2022年10月至2023年2月普通医学第4剂二价mRNA疫苗人群感染新冠肺炎的危险因素
背景:接种第4剂mRNA新冠肺炎疫苗的人感染新冠肺炎的风险因素仍然是争论的主题。目的:确定第4剂二价mRNA疫苗接种人群中新冠肺炎的危险因素和保护因素。地点:托莱多(西班牙)的全科医生咨询。方法:对2022年10月1日至2023年2月28日接种第四剂二价mRNA疫苗的人群中有或无新冠肺炎感染的成年患者的病例和对照进行纵向和前瞻性研究。结果:纳入了5例接种第4剂疫苗的人的新冠肺炎感染病例,并与52例对照组(接种第4针和接种加强针后未接种新冠肺炎)进行了比较。第4剂新冠肺炎感染的危险因素为:女性(RR=1.67)、社会卫生保健工作者(RR=10.39;p=0.0349)、血液慢性病(RR=6.9)。p=0.0322)、慢性内分泌疾病(RR=2.72。p=0.039425)和循环系统慢性病(RR=1.87)。结论:在西班牙托莱多的全科医疗环境中,作为一名社会卫生保健工作者和患有可能与免疫抑制相关的慢性病是接种第四剂二价mRNA疫苗的人感染新冠肺炎的统计学显著危险因素。尽管接种了第4剂mRNA新冠肺炎疫苗,但接触或免疫抑制最严重的人群仍有感染SARS-CoV-2的风险,因此建议在这些人群中采取其他预防方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信